/Investor DB

Connecticut Innovations — 2021 Investments

7 investments dated 2021 · listed companies and verified rows first · show all

Advanced Telepsych, Inc.advancedtelepsych.orginJan 2021

Advanced TelePsych provides telepsychiatry services, including psychiatric evaluation and medication management, delivered by psychiatric professionals and mental health providers.

Digital HealthHealthtechMental HealthLongmeadow, US

Andrew Zaback(Executive Officer)

CakeHealthcakehealth.com𝕏Oct 2021 · $1.5M

Cakehealth.com is a health information and product-review website presented as merged with Dualdiagnosis.org, covering topics such as CBD, medical trends, mental and physical health, and supplement product tests.

ConsumerHealthtechMedia & EntertainmentWellness & Fitness

Andy BrettRebecca Woodcockin

Co-investors500 GlobalI2BF Global VenturesLaunch Capital

CoreChain Technologiescorechain.techin𝕏Aug 2021Acquired

Corechain provides a B2B payments platform that streamlines paperless payments and supply chain financing to help suppliers unlock working capital from unpaid invoices.

B2B MarketplacesEnterprise SoftwareFintechSaaSNew Haven, US

Chris Aguas(Founder)inRandy Shuken(Director)Thomas G Romary(Executive Officer, Director)

BoardSteve Reale(Director)inJoseph Giordano(Director)in

Co-investorsBloccelerate VCChain ReactionNext Coast VenturesUlu VenturesMotivate Venture CapitalNew Form Capital

Corismacorismacv2025.cominAug 2021

Corisma develops a fully implanted transcatheter mechanical circulatory support system for advanced heart failure patients, designed to bridge acute and chronic care with improved quality of life.

BiotechDeep TechHealthtechMedical DevicesHamden, US

R. William Vogel(Chief Executive Officer)inYuhang Zhao(Director)Michael Theran(Executive Officer, Director)

BoardKaushik Mandal(Chairman)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Surface Travel Inc. d/b/a CuracityLumedaSmartPay

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.